Search
for
Sort by
Research 181–210 of 274
- Topical Treatments for Scalp Psoriasis
- Latanoprost-induced Skin Depigmentation
- Medication Repurposing: New Uses for Old Drugs
- Ottawa, Ontario, Canada, February 13–16, 2013
- Discovery of New Drug Therapies Based on the Study of Adverse Reactions
- Clinical Trials and Hair Loss
- Signal Mining for Non-Bleeding Adverse Event in Novel Oral Anticoagulants: A Pharmacovigilance Study Based on the FAERS Database
- Encapsulación en ciclodextrinas de compuestos con actividad frente a la alopecia androgénica masculina.
- Teriflunomide and Its Mechanism of Action in Multiple Sclerosis
- Adverse Side Effects of 5α‐Reductase Inhibitors Therapy: Persistent Diminished Libido and Erectile Dysfunction and Depression in a Subset of Patients
- Testosterone therapy for transgender men
- A review of diagnosis and treatment of acne in adult female patients
- Effects of 5-alpha reductase inhibitors on erectile function, sexual desire and ejaculation
- Age-related hair changes in men: Mechanisms and management of alopecia and graying
- Teriflunomide (Aubagio®) for the treatment of multiple sclerosis
- Assessing the real-world safety of tralokinumab for atopic dermatitis: insights from a comprehensive analysis of FAERS data
- Emerging Therapies for Acne Vulgaris
- Finasteride and Male Breast Cancer: Does the MHRA Report Show a Link?
- Role of skin enzymes in metabolism of topical drugs
- Dermatological medications and local therapeutics
- Abstracts
- Evaluation of bioequivalence of five 0.1 mg dutasteride capsules compared to one 0.5 mg dutasteride capsule: a randomized study in healthy male volunteers
- Evaluation of dermatologic adverse events associated with aromatase inhibitors: insights from the FAERS database
- The Novel Excipient, Dodecyl-2-N, N-dimethylaminopropionate Hydrochloride (DDAIP-HCl) Improves the Flux of Minoxidil in Human Skin
- Benefit-Risk Assessment of GLP-1 Receptor Agonists: Implications for Dermatologists and Plastic Surgeons
- Dermatological drugs, topical agents, and cosmetics
- Telogen Effluvium and Metabolic Stress in Modern Weight Loss Interventions: A Narrative Clinical Review
- Physician Awareness of the Safe Use of Cyproterone Acetate in Europe: A Survey on the Effectiveness of Additional Risk Minimization Measures
- Alopecias
- Real-world safety of ixekizumab: a disproportionality analysis using the FDA adverse event reporting system and the VigiAccess databases